FDA Approved: ADEMPAS — Original Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Adempas (riociguat) from Bayer as the original application for treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Adempas (riociguat)

Snippet

ORIG AP for ADEMPAS (RIOCIGUAT)